Two Japanese companies will soon start testing investors’ appetite for their shares, with one of the listings likely to be the country’s largest this year.
Related Posts
Bulgogi Tacos, Fire Pits and Tequila Bars: Concertgoers Shell Out for VIP Treatment
Venues are offering more options to superfans seeking to swap sticky floors for souped-up suites.
Regeneron, Sanofi Get FDA OK for Dupixent to Treat COPD
Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Oneok to Acquire EnLink Midstream in $4.3 Billion Stock Deal
Oneok shares will be used to acquire all of the outstanding publicly held units of EnLink Midstream for $4.3 billion.